These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 34292518)
1. Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims. Senna M; Ko J; Tosti A; Edson-Heredia E; Fenske DC; Ellinwood AK; Rueda MJ; Zhu B; King B Adv Ther; 2021 Sep; 38(9):4646-4658. PubMed ID: 34292518 [TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database. Hammadi AA; Parmar NV; Farghaly M; Dallal SA; Zayed MWA; Ebeid F; Subramanyam K; Ramachandrachar BC; Ahmed HM J Dermatol; 2024 Sep; 51(9):1157-1171. PubMed ID: 39051178 [TBL] [Abstract][Full Text] [Related]
3. Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective. Fenske DC; Ding Y; Morrow P; Smith SG; Silver MK; Moynihan M; Manjelievskaia J J Manag Care Spec Pharm; 2023 Apr; 29(4):409-419. PubMed ID: 36989453 [No Abstract] [Full Text] [Related]
4. All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States. Mostaghimi A; Gandhi K; Done N; Ray M; Gao W; Carley C; Wang T; Swallow E; Sikirica V J Manag Care Spec Pharm; 2022 Apr; 28(4):426-434. PubMed ID: 35332790 [No Abstract] [Full Text] [Related]
5. Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database. Campos-Alberto E; Hirose T; Napatalung L; Ohyama M J Dermatol; 2023 Jan; 50(1):37-45. PubMed ID: 36321512 [TBL] [Abstract][Full Text] [Related]
6. Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata. Ray M; Swallow E; Gandhi K; Carley C; Sikirica V; Wang T; Done N; Signorovitch J; Mostaghimi A J Health Econ Outcomes Res; 2022; 9(2):11-18. PubMed ID: 35975139 [No Abstract] [Full Text] [Related]
7. Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan's National Health Insurance Research Database. Tsai TF; Huang YH; Wei CY; Ng KJ; Newson RS; Lee TH; Shen D; Wang BCM; Tang CH Value Health Reg Issues; 2024 Sep; 43():101007. PubMed ID: 38865765 [TBL] [Abstract][Full Text] [Related]
8. Real-World Claims Analyses of Comorbidity Burden, Treatment Pattern, Healthcare Resource Utilization, and Costs in Pediatric Psoriasis. Edson-Heredia E; Anderson S; Guo J; Zhu B; Malatestinic WN; Wine-Lee L; Swanson E Adv Ther; 2021 Jul; 38(7):3948-3961. PubMed ID: 34091866 [TBL] [Abstract][Full Text] [Related]
9. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. Huang KP; Mullangi S; Guo Y; Qureshi AA JAMA Dermatol; 2013 Jul; 149(7):789-94. PubMed ID: 23700152 [TBL] [Abstract][Full Text] [Related]
10. Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study. Vañó-Galván S; Figueras-Nart I; Artime E; Díaz-Cerezo S; Núñez M; Iglesias C; Artés M; Huete T Eur J Dermatol; 2024 Apr; 34(2):163-175. PubMed ID: 38907547 [TBL] [Abstract][Full Text] [Related]
11. Treatment Patterns for Alopecia Areata in the US. Lee H; Huang KP; Mostaghimi A; Choudhry NK JAMA Dermatol; 2023 Nov; 159(11):1253-1257. PubMed ID: 37728940 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology, management and the associated burden of mental health illness, atopic and autoimmune conditions, and common infections in alopecia areata: protocol for an observational study series. Harries M; Macbeth AE; Holmes S; Thompson AR; Chiu WS; Gallardo WR; Messenger AG; Tziotzios C; de Lusignan S BMJ Open; 2021 Nov; 11(11):e045718. PubMed ID: 34785540 [TBL] [Abstract][Full Text] [Related]
13. Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries. Vañó-Galván S; Egeberg A; Piraccini BM; Marwaha S; Reed C; Johansson E; Durand F; Bewley A Dermatol Ther (Heidelb); 2024 Apr; 14(4):1027-1037. PubMed ID: 38509379 [TBL] [Abstract][Full Text] [Related]
14. Real world evidence: patients with alopecia areata in Italy. Perrone V; Sabatino S; Avitabile A; Dovizio M; Leogrande M; Degli Esposti L Ital J Dermatol Venerol; 2024 Apr; 159(2):182-189. PubMed ID: 38650498 [TBL] [Abstract][Full Text] [Related]
15. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population. Mostaghimi A; Gao W; Ray M; Bartolome L; Wang T; Carley C; Done N; Swallow E JAMA Dermatol; 2023 Apr; 159(4):411-418. PubMed ID: 36857069 [TBL] [Abstract][Full Text] [Related]
16. Immune-Mediated and Psychiatric Comorbidities Among Patients Newly Diagnosed With Alopecia Areata. Mostaghimi A; Soliman AM; Li C; Barqawi YK; Grada A JAMA Dermatol; 2024 Sep; 160(9):945-952. PubMed ID: 39083282 [TBL] [Abstract][Full Text] [Related]
17. Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA. Mostaghimi A; Xenakis J; Meche A; Smith TW; Gruben D; Sikirica V Dermatol Ther (Heidelb); 2022 Apr; 12(4):1027-1040. PubMed ID: 35381975 [TBL] [Abstract][Full Text] [Related]
18. Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study. Miyazaki C; Sruamsiri R; Mahlich J; Jung W PLoS One; 2020; 15(5):e0232738. PubMed ID: 32442204 [TBL] [Abstract][Full Text] [Related]